Recursion Pharmaceuticals, Inc.
NASDAQRXRX short interest utilization hits 90.95%, near 52-week peak of 100%, signaling acute scarcity of borrowable shares for short sellers.
No long-form analysis yet for RXRX. Pulse alerts and the live data picture are available on ORTEX.
Open RXRX on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RXRX — free to start on ORTEX.
Sign up for free →Open RXRX on ORTEXSnapshot as of 26 Jun 2026
Pulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live RXRX data →